Clinical Trial Update: Response of VEGF and AT-II to HCG in PCOS [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial investigated the responses of VEGF and angiotensin II to human chorionic gonadotropin (HCG) in women with Polycystic Ovary Syndrome; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Human chorionic gonadotropin (human chorionic gonadotropin)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Polycystic Ovary Syndrome | EARLY_Phase 1 | Status: COMPLETED